Immunotech Laboratories, Inc.
IMMB · OTC
12/31/2016 | 9/30/2016 | 6/30/2016 | 9/30/2006 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0 | -0 | -1 |
| % Growth | 51.6% | -103.1% | 100% | – |
| Operating Cash Flow | – | – | – | -$0 |
| Capital Expenditures | – | – | – | -$0 |
| Free Cash Flow | – | – | – | -$0 |